Trial intelligence / Profile preview

MRP-HAND: Multiprofen-CC for Hand Osteoarthritis Pain

NCT06966206Phase 3Recruiting

Sponsor
St. Joseph's Healthcare Hamilton
Start
Mar 2026
Primary completion
Dec 2026
Modality
Transdermal Patches, Hydrogel Systems, Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of multiprofen-cc in hand osteoarthritis (2 arms), sponsored by St. Joseph's Healthcare Hamilton. Primary endpoint: Pain intensity at 6 weeks. Started Mar 2026; status: recruiting.

02

Drugs

multiprofen-cc
03

Conditions

hand osteoarthritis

Beyond the preview

Go deeper on NCT06966206.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06966206.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call